Aier Eye Hospital Group Co., Ltd. (SHE:300015)
China · Delayed Price · Currency is CNY 8.53
+0.02 (0.24%)
Aug 26, 2026, 3:04 PM CST
Aier Eye Hospital Group Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 78,872 | 102,066 | 123,187 | 147,575 | 222,975 | 228,569 | |
Market Cap Growth | -36.68% | -17.14% | -16.53% | -33.81% | -2.45% | -25.95% |
Enterprise Value | 81,263 | 103,659 | 124,932 | 145,670 | 220,117 | 229,715 |
Last Close Price | 8.51 | 10.78 | 12.85 | 15.15 | 22.80 | 23.81 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 23.41 | 31.50 | 34.64 | 43.94 | 88.33 | 98.38 |
Forward PE | 22.98 | 25.00 | 33.20 | 35.69 | 67.40 | 89.50 |
PS Ratio | 3.47 | 4.57 | 5.87 | 7.25 | 13.84 | 15.24 |
PB Ratio | 3.20 | 4.36 | 5.65 | 7.37 | 12.66 | 18.70 |
P/TBV Ratio | 6.26 | 8.91 | 10.80 | 12.84 | 21.44 | 36.62 |
P/FCF Ratio | 20.27 | 26.31 | 40.37 | 33.45 | 71.87 | 88.25 |
P/OCF Ratio | 13.46 | 17.09 | 25.24 | 25.13 | 49.65 | 55.97 |
PEG Ratio | 2.13 | 1.76 | 4.05 | 1.28 | 2.22 | 3.12 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 3.58 | 4.64 | 5.95 | 7.15 | 13.66 | 15.31 |
EV/EBITDA Ratio | 12.26 | 18.56 | 23.57 | 24.65 | 48.84 | 50.92 |
EV/EBIT Ratio | 16.69 | 22.08 | 28.04 | 27.89 | 56.63 | 57.12 |
EV/FCF Ratio | 20.89 | 26.72 | 40.94 | 33.02 | 70.95 | 88.69 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.29 | 0.31 | 0.31 | 0.28 | 0.26 | 0.45 |
Debt / EBITDA Ratio | 1.09 | 1.12 | 1.12 | 0.85 | 0.90 | 1.10 |
Debt / FCF Ratio | 1.86 | 1.86 | 2.22 | 1.27 | 1.47 | 2.11 |
Net Debt / Equity Ratio | 0.03 | 0.04 | 0.03 | -0.06 | -0.13 | 0.06 |
Net Debt / EBITDA Ratio | 0.14 | 0.16 | 0.13 | -0.22 | -0.52 | 0.17 |
Net Debt / FCF Ratio | 0.21 | 0.22 | 0.23 | -0.30 | -0.76 | 0.30 |
Asset Turnover | 0.64 | 0.64 | 0.66 | 0.72 | 0.67 | 0.80 |
Inventory Turnover | 12.36 | 12.03 | 11.55 | 12.29 | 12.26 | 13.53 |
Quick Ratio | 1.25 | 1.07 | 1.26 | 1.51 | 1.62 | 1.03 |
Current Ratio | 1.44 | 1.24 | 1.45 | 1.69 | 1.80 | 1.15 |
Return on Equity (ROE) | 15.19% | 15.37% | 17.86% | 19.43% | 18.02% | 21.59% |
Return on Assets (ROA) | 8.55% | 8.39% | 8.78% | 11.50% | 10.03% | 13.45% |
Return on Invested Capital (ROIC) | 15.46% | 15.76% | 17.58% | 24.70% | 22.18% | 28.49% |
Return on Capital Employed (ROCE) | 16.50% | 16.50% | 16.80% | 21.60% | 18.30% | 25.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 4.27% | 3.17% | 2.89% | 2.28% | 1.13% | 1.02% |
FCF Yield | 4.93% | 3.80% | 2.48% | 2.99% | 1.39% | 1.13% |
Dividend Yield | 2.37% | 1.67% | 1.25% | 0.99% | 0.34% | 0.30% |
Payout Ratio | 67.10% | 47.08% | 39.91% | 22.24% | 26.64% | 28.52% |
Buyback Yield / Dilution | -0.27% | -0.27% | 0.07% | -2.10% | -0.07% | -1.48% |
Total Shareholder Return | 2.10% | 1.40% | 1.32% | -1.11% | 0.27% | -1.18% |